Abstract
In a randomised single blind study, pivampicillin was compared with erythromycin in women with urogenital Chlamydia trachomatis infections. The pivampicillin dosage was 700 mg twice a day and the erythromycin dosage 500 mg twice a day for seven days. Follow up took place on days 7 and 14 after the start of treatment. All 26 women treated with pivampicillin were culture negative for chlamydiae at the first and second follow up visits. All 23 women who received erythromycin were culture negative at the first follow up visit, but one was culture positive at the second follow up visit. Gastrointestinal side effects were recorded in five patients receiving pivampicillin and in nine receiving erythromycin. Two patients receiving erythromycin were withdrawn from treatment because of gastrointestinal disturbances, compared with none receiving pivampicillin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander E. R., Harrison H. R. Role of Chlamydia trachomatis in perinatal infection. Rev Infect Dis. 1983 Jul-Aug;5(4):713–719. doi: 10.1093/clinids/5.4.713. [DOI] [PubMed] [Google Scholar]
- Bowie W. R. Epidemiology and therapy of Chlamydia trachomatis infections. Drugs. 1984 May;27(5):459–468. doi: 10.2165/00003495-198427050-00005. [DOI] [PubMed] [Google Scholar]
- Hagdrup H., Kristensen J., Scheibel J. Failure of pivampicillin in treating chlamydial infections. Br J Vener Dis. 1984 Jun;60(3):204–204. doi: 10.1136/sti.60.3.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johannisson G., Sernryd A., Lycke E. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo. Sex Transm Dis. 1979 Apr-Jun;6(2):50–57. doi: 10.1097/00007435-197904000-00002. [DOI] [PubMed] [Google Scholar]
- Møller B. R., Cramers M., From E. Pivampicillin in treating genital infection with Chlamydia trachomatis. Genitourin Med. 1985 Aug;61(4):264–265. doi: 10.1136/sti.61.4.264. [DOI] [PMC free article] [PubMed] [Google Scholar]